Prolonged remission of HIV-associated multicentric Castelman's disease with an anti-CD20 monoclonal antibody as primary therapy

AIDS. 2003 Jun 13;17(9):1409-10. doi: 10.1097/00002030-200306130-00023.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology*
  • Antiviral Agents / therapeutic use*
  • Castleman Disease / therapy*
  • HIV Infections / therapy*
  • Humans
  • Male
  • Remission Induction / methods
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Antiviral Agents
  • Rituximab